Search - tctmd.com

Displaying 881 - 900 of 1758

Sort: Relevancy | Date

Presentation TCT 2017

Developing a STEMI System of Care for Low and Middle Income Countries: The STEMI India Model

Presenter: Vinay K. Bahl, Alice K. Jacobs, Thomas Alexander

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presenter: Gilles Dreyfus, Sanjay Kaul, Raj Makkar

November 01, 2017

Presentation TCT 2017

Cardiovascular Care in the Era of Facebook

Presenter: Stephanie Gutch, Ajay J. Kirtane, Kapil Yadav

November 01, 2017

Presentation TCT 2017

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Medical Therapy in Group I Pulmonary Arterial Hypertension: Efficacy and Safety

Presenter: Irene M. Lang, Ehtisham Mahmud, Rajesh Gupta

November 01, 2017

Presentation TCT 2017

TAVR: Current Devices and Indications

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Vinod H. Thourani

November 01, 2017

Presentation TCT 2017

Cooperation Between Italian Society of Interventional Cardiology (GISE) and the Bulgarian Cardiac Institute in Bulgaria: Impressive Reduction in the Mortality of CAD

Presenter: Vinay K. Bahl, Alice K. Jacobs, Farhat Fouladvand

November 01, 2017

Presentation TCT 2017

Social Media and Interventional Cardiology: High Risk or Routine?

Presenter: Stephanie Gutch, Ajay J. Kirtane, Asif Qasim

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Combat Cardiology: From the Cath Lab to Battlefield Rescue

Presenter: Vinay K. Bahl, Alice K. Jacobs, Paul Rees

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Social Media: The New Platform for Influence in Interventional Cardiology

Presenter: Stephanie Gutch, Ajay J. Kirtane, Gregory D Matthews

November 01, 2017

Presentation TCT 2017

Streamlining Interventional Cardiology Practice Using a Smartphone in India

Presenter: Vinay K. Bahl, Alice K. Jacobs, Nishith Chandra

November 01, 2017

Presentation TCT 2017

Beyond Angiography: iFR, FFR, and Intravascular Imaging for PCI Optimization

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Verghese Mathew

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Social Media and the Interventionalist: A Great Fit

Presenter: Stephanie Gutch, Ajay J. Kirtane, R. Jay Widmer

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Advertisement

Developing a STEMI System of Care for Low and Middle Income Countries: The STEMI India Model

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Cardiovascular Care in the Era of Facebook

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Medical Therapy in Group I Pulmonary Arterial Hypertension: Efficacy and Safety

TAVR: Current Devices and Indications

Cooperation Between Italian Society of Interventional Cardiology (GISE) and the Bulgarian Cardiac Institute in Bulgaria: Impressive Reduction in the Mortality of CAD

Social Media and Interventional Cardiology: High Risk or Routine?

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Combat Cardiology: From the Cath Lab to Battlefield Rescue

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Social Media: The New Platform for Influence in Interventional Cardiology

Streamlining Interventional Cardiology Practice Using a Smartphone in India

Beyond Angiography: iFR, FFR, and Intravascular Imaging for PCI Optimization

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Social Media and the Interventionalist: A Great Fit

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

Should Pre-Diabetes Affect Revascularization Decisions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content